Aging · 2021 · 30 citations · 32 references
MedicineCancer BiologyCell BiologyCell ProliferationCell SignalingMolecular OncologyCancer Cell SignalingCancer ProgressionGlioblastomaMalignant NeoplasmsOncogenic Signaling PathwaysCancer Cell Proliferation InhibitionCancer Cell Survival SignalingCancer Signaling PathwaysGlioblastoma Cell SignalingGlioblastoma Molecular PathwaysGlioblastoma Tumor BiologyTumor Cell Survival Pathways
. Mechanistically, NAP1L1 could interact with HDGF at the protein level and they co-localize in the cytoplasm. HDGF knockdown in NAP1L1-overexpressing glioma cells significantly inhibited cell proliferation. Furthermore, HDGF could interact with c-Jun, an oncogenic transcription factor, which eventually induced the expressions of cell cycle promoters, CCND1/CDK4/CDK6. This finding suggested that NAP1L1 could interact with HDGF, and the latter recruited c-Jun, a key oncogenic transcription factor, that further induced CCND1/CDK4/CDK6 expression, thereby promoting proliferation and chemoresistance in glioma cells. High expression of NAP1L1 in glioma tissues indicated shorter overall survival in glioma patients.
32
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin, Ignacio Arganda‐Carreras, Erwin Frise et al. · Nature Methods · 2012 · 70.9K citations
A restricted cell population propagates glioblastoma growth after chemotherapy
Jian Chen, Yanjiao Li, Tzong‐Shiue Yu et al. · Nature · 2012 · 2.3K citations
Medicine, Cancer Biology, Oncology +14
Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin
Lihua Min, Yuan Ji, Latifa Bakiri et al. · Nature Cell Biology · 2012 · 250 citations
Medicine, Cancer Biology, Oncology +14
Ye Song, Qisheng Luo, Hao Long et al. · Molecular Cancer · 2014 · 228 citations · Full text
Medicine, Cancer Biology, Oncology +16